Keywords: encore, sees, promise, r-flurbiprofen, pharmaceuticals, start-up, company

Encore sees promise with R-flurbiprofen

Article | 18 April 2000

Print This

Encore Pharmaceuticals, a US start-up company, says that its leadcompound, R-flurbiprofen (E-7869), has been shown to be safe in a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in